APA (7th ed.) Citation

Schneider, B. P., Li, L., Shen, F., Miller, K. D., Radovich, M., O'Neill, A., . . . Smith, M. L. (2014). Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100. British Journal of Cancer, 111(6), 1241. https://doi.org/10.1038/bjc.2014.430

Chicago Style (17th ed.) Citation

Schneider, B P., et al. "Genetic Variant Predicts Bevacizumab-induced Hypertension in ECOG-5103 and ECOG-2100." British Journal of Cancer 111, no. 6 (2014): 1241. https://doi.org/10.1038/bjc.2014.430.

MLA (9th ed.) Citation

Schneider, B P., et al. "Genetic Variant Predicts Bevacizumab-induced Hypertension in ECOG-5103 and ECOG-2100." British Journal of Cancer, vol. 111, no. 6, 2014, p. 1241, https://doi.org/10.1038/bjc.2014.430.